← positive_eps_streak (all companies) · MYGN (all signals) · all methodology

positive_eps_streak on MYRIAD GENETICS INC (MYGN)

SIC 2835 — In Vitro & In Vivo Diagnostic Substances · CIK 899923 · default direction: long

Definition

Fires on companies with consecutive years of positive earnings — quality compounder candidates. Surfaces stable franchises with earnings durability, not speculative growth.

Every time the signal fired on MYGN

FYFiling dateEvent date1d5d20d60d252d
FY20192019-08-132019-08-13-42.76%-45.03%-39.39%-47.92%-70.66%
FY20182018-08-242018-08-24+1.40%+2.41%-3.48%-33.79%-54.59%
FY20172017-08-092017-08-09-2.79%-0.46%+15.87%+2.07%+53.82%
FY20162016-08-102016-08-10+5.58%+6.40%+2.89%-17.46%+38.07%
FY20152015-08-122015-08-12+2.17%+2.80%+15.63%+34.04%-37.35%
FY20142014-08-132014-08-13+0.14%+4.08%+1.47%-3.50%-5.88%
FY20132013-08-142013-08-14-1.85%-2.20%-4.44%-7.14%+28.25%
FY20122012-08-152012-08-15-3.16%-0.32%+8.36%+20.05%+8.08%

Forward returns are stock returns from event date (next trading day after filing). Sign is raw stock direction; the trade direction is in the calibration table below.

Universe-wide calibration (this signal across all companies)

Horizonn eventsGross stock retHit rateTrade dirNet PnLCost (bps)r/σ net
1d21,256+0.05%+49.53%long-0.16%22-0.04
5d21,258+0.10%+50.10%long-0.10%22-0.00
20d21,218-0.80%+49.80%long-1.03%22-0.04
60d19,852+1.64%+54.15%long+1.48%22+0.04
252d19,501+13.65%+64.44%long+13.47%22+0.27

Net PnL is direction × stock return − round-trip execution cost (5 bps half-spread + ADV-tiered borrow). See positive_eps_streak methodology for the full audit.


Data: /api/company/899923/financials